Targeting genes in the renin-angiotensin system

Current Opinion in Nephrology and Hypertension

Volumn 17, Issue 1, 2008, Pages 57-63

  Le, Thu H ^a   Coffman, Thomas M ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Angiotensin receptors; Angiotensin converting enzyme 2; Hypertension; mouse

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; RENIN;

BLOOD PRESSURE REGULATION; CLINICAL MEDICINE; DRUG MECHANISM; GENE TARGETING; HUMAN; HYPERTENSION; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSINOGEN; ANIMALS; GENE TARGETING; HUMANS; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, ANGIOTENSIN; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 37349012187     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3282f2fd39     Document Type: Review

References (70)

1. Bronson S, Smithies O. Altering mice by homologous recombination using embryonic stem cells. J Biol Chem 1994; 269:27155-27158.
2. Friberg P, Sundelin B, Bohman S-O, et al. Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 1994; 45:485-492.
3. Grady E, Sechi L, Griffn C, et al. Expression of AT2 receptors in the developing rat fetus. J Clin Invest 1991; 88:921-933.
4. Kakuchi J, Ichiki T, Kiyama S, et al. Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 1995; 47:140-147.
5. Millan M, Carvallo P, Izumi S-I, et al. Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 1989; 244:1340-1342.
6. Kim HS, Krege JH, Kluckman KD, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 1995; 92:2735-2739.
7. Niimura F, Labosky PA, Kakuchi J, et al. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 1995; 96:2947-2954.
8. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
9. Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99:1786-1797.
10. Smithies O, Kim H-S. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci USA 1994; 91:3612-3615.
11. Bock HA, Hermle M, Brunner FP, et al. Pressure dependent modulation of renin release in isolated perfused glomeruli. Kidney Int 1992; 41:275-280.
12. Carey RM, McGrath HE, Pentz ES, et al. Biomechanical coupling in renin-releasing cells. J Clin Invest 1997; 100:1566-1574.
13. Bell PD, Lapointe JY, Sabirov R, et al. Macula densa cell signaling involves ATP release through a maxi anion channel. Proc Natl Acad Sci U S A 2003; 100:4322-4327.
14. Lorenz JN, Weihprecht H, He XR, et al. Effects of adenosine and angiotensin on macula densa-stimulated renin secretion. Am J Physiol 1993; 265 (2 Pt 2):F187-F194.
15. Sigmund CD, Gross KW. Structure, expression, and regulation of the murine renin genes. Hypertension 1991; 18:446-457.
16. Sharp MG, Fettes D, Brooker G, et al. Targeted inactivation of the Ren-2 gene in mice. Hypertension 1996; 28:1126-1131.
17. Takahashi N, Lopez ML, Cowhig JE Jr, et al. Ren1c homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type. J Am Soc Nephrol 2005; 16:125-132.
18. Yanai K, Saito T, Kakinuma Y, et al. Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. J Biol Chem 2000; 275:5-8.
19. Nguyen G, Delarue F, Burckle C, et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109:1417-1427.
20. Burckle C, Bader M. Prorenin and its ancient receptor. Hypertension 2006; 48:549-551.
21. Amsterdam A, Nissen R, Sun Z, et al. Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci U S A 2004; 101:12792-12797.
22. Luft F. Renin and its putative receptor remain enigmas. J Am Soc Nephrol 2007; 18:1987-1994.
23. Takahashi H, Ichihara A, Kaneshiro Y, et al. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol 2007; 18:2054-2061.
24. Corvol P, Williams T, Soubrier F. Peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods Enymol 1995; 248:283-305.
25. Ehlers M, Fox E, Strydom D, et al. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotenisn-converting enzyme. Proc Natl Acad Sci U S A 1989; 86:7741-7745.
26. Hubert C, Houot A, Corvol P, et al. Structure of the angiotensin I-converting enzyme gene: two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991; 266:15377-15383.
27. Esther C, Howard T, Marino E, et al. Mice lacking angiotensin converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 1996; 74:953-965.
28. Krege J, John S, Langenbach L, et al. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995; 375:146-149.
29. Fuchs S, Frenzel K, Hubert C, et al. Male fertility is dependent on dipeptidase activity of testis ACE. Nature Med 2005; 11:1140-1142.
30. Esther C, Marino E, Howard T, et al. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 1997; 99:2375-2385.
31. Cole J, Quach DL, Sundaram K, et al. Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure. Circ Res 2002; 90:87-92.
32. Donoghue M, Hsieh F, Baronas E, et al. A novel ACE-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin1-9. Circ Res 2000; 87:1-9.
33. Tipnis S, Hooper N, Hyde R, et al. A human homolog of angiotensin-converting enzyme. J Biol Chem 2000; 275:33238-33243.
34. Zhang H, Wada J, Hida K, et al. Collectrin, a collecting duct-specific membrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem 2001; 276:17132-17139.
35. Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277:14838-14843.
36. Ferrario C, Brosnihan K, Diz D, et al. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension 1991; 18:III-126-III-133.
37. Santos RA, Simoes e Silva AC, Maric C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 2003; 100:8258-8263.
38. Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417:822-828.
39. Yamamoto K, Ohishi M, Katsuya T, et al. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 2006; 47:718-726. This paper reported that ACE2-deficient mice have normal cardiac function at baseline, but they develop an accelerated course of cardiac dysfunction after aortic banding.
40. Gurley S, Allred A, Le T, et al. Altered blood pressure responses with normal cardiac function in ACE2-null mice. J Clin Invest 2006; 116:2218-2225. ACE2-deficient mice on two inbred backgrounds do not have cardiac dysfunction, but they are more susceptible to angiotensin II-associated hypertension.
41. Malakauskas SM, Quan H, Fields TA, et al. Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. Am J Physiol Renal Physiol 2007; 292:F533-F544. Mice deficient in the ACE2 homologue collectrin have generalized aminoaciduria with altered expression and function of luminal amino acid transporters.
42. Danilczyk U, Sarao R, Remy C, et al. Essential role for collectrin in renal amino acid transport. Nature 2006; 444:1088-1091. Mice deficient in the ACE2 homologue collectrin have generalized amino aciduria with altered expression and function of luminal amino acid transporters.
43. Akpinar P, Kuwajima S, Krutzfeldt J, et al. Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. Cell Metab 2005; 2:385-397.
44. Fukui K, Yang Q, Cao Y, et al. The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab 2005; 2:373-384.
45. Timmermans PB, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45:205-251.
46. Yoshida H, Kakuchi J, Guo D-F, et al. Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human). Biochem Biophys Res Commun 1992; 186:1042-1049.
47. Chiu A, Dunscomb J, McCall D, et al. Characterization of angiotensin AT1A receptor isoform by its ligand binding signature. Regul Pept 1993; 44:141-147.
48. Burson JM, Aguilera G, Gross KW, et al. Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol 1994; 267 (2 Pt 1):E260-E267.
49. Gasc JM, Shanmugam S, Sibony M, et al. Tissue-specific expression of type 1 angiotensin II receptor subtypes: an in situ hybridization study. Hypertension 1994; 24:531-537.
50. Llorens-Cortes C, Greenberg B, Huang H, et al. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 1994; 24:538-548.
51. Timmermans P, Chiu A, Herblin W, et al. Angiotensin II receptor subtypes. Am J Hypertens 1992; 5:406-410.
52. Ito M, Oliverio MI, Mannon PJ, et al. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A 1995; 92:3521-3525.
53. Matsusaka T, Nishimura H, Utsunomiya H, et al. Chimeric mice carrying 'regional' targeted deletion of the angiotensin type 1A receptor gene: evidence against the role for local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells. J Clin Invest 1996; 98:1867-1877.
54. Sugaya T, Nishimatsu S, Tanimoto K, et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 1995; 270:18719-18722.
55. Oliverio M, Best C, Ito M, et al. Normal growth and development in mice lacking type 1A receptors for angiotensin II. J Am Soc Neph 1995; 6:704A.
56. Le T, Fogo A, Salzer H, et al. A modifier locus on chromosome 3 for renal vascular pathology in AT1A receptor-deficiency. Hypertension 2004; 43:445-451.
57. Chen X, Li W, Yoshida H, et al. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol Renal Physiol 1997; 272:F299-F304.
58. Oliverio MI, Kim HS, Ito M, et al. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A 1998; 95:15496-15501.
59. Oliverio MI, Best CF, Kim HS, et al. Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation. Am J Physiol 1997; 272 (4 Pt 2):F515-F520.
60. Davisson RL, Oliverio MI, Coffman TM, et al. Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 2000; 106:103-106.
61. Tsuchida S, Matsusaka T, Chen X, et al. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 1998; 101:755-760.
62. Guyton AC. Blood pressure control: special role of the kidneys and body fluids. Science 1991; 252:1813-1816.
63. Crowley SD, Gurley SB, Oliverio MI, et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the rennin-angiotensin system. J Clin Invest 2005; 115:1092-1099.
64. Crowley S, Gurley S, Harrera M, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 2006; 103:17985-17990. AT1 receptors in the kidney play a dominant role in the development of angiotensin II-dependent hypertension and one of its major contributions, cardiac hypertrophy.
65. Nio Y, Matsubara H, Murasawa S, et al. Regulation of gene transciption of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995; 95:46-54.
66. Ichiki T, Labosky PA, Shiota C, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377:748-750.
67. Hein L, Barsh GS, Pratt RE, et al. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995; 377:744-747.
68. Siragy HM, Inagami T, Ichiki T, et al. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A 1999; 96:6506-6510.
69. Iwai M, Liu HW, Chen R, et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 2004; 110:843-848.
70. Iwai M, Chen R, Li Z, et al. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 2005; 112:1636-1643.